Torrent Pharma Ltd. Share Price & Stock Analysis

Torrent Pharma Ltd. (BSE: 500420) is an Ahmedabad, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹1,79,494 Cr, it ranks #52 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹4,670.00 (as of 16 Nov 2026), the share price is 11.0% below its 52-week high of ₹5,250.00 and 27.2% above its 52-week low of ₹3,672.30. The share price is up 30.4% over one year and down 5.0% over three months.

Key Metrics

Current Price₹4,670.00
Market Cap₹1,79,494 Cr
BSE Code500420
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio73.6
Return on Equity16.98%
Return on Assets7.25%
52-Week Range₹3,672.30 – ₹5,250.00
1-Year Price Change+30.4%
3-Month Price Change-5.0%
Beta (1Y)0.28
Dividend Yield0.38%
HeadquartersAhmedabad, Gujarat
Websitewww.torrentpharma.com

Latest Quarterly Results — Q2 FY27

Revenue₹4,979 Cr
Net Profit₹534 Cr
Net Margin10.7%
EPS (Basic)₹14.05
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Torrent Pharma Ltd. Quarterly Revenue and Profit Trend

Torrent Pharma Ltd. reported revenue of ₹4,979 Cr in Q2 FY27, up 50.8% from ₹3,302 Cr in Q2 FY26 and up 1.2% from ₹4,921 Cr in Q1 FY27. It posted a net profit of ₹534 Cr for the quarter, against a net profit of ₹591 Cr in Q2 FY26 (down 9.6%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹2,959 Cr (Q4 FY25) to ₹4,979 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹4,979 Cr₹534 Cr10.7%
Q1 FY27₹4,921 Cr₹566 Cr11.5%
Q4 FY26₹4,197 Cr₹364 Cr8.7%
Q3 FY26₹3,303 Cr₹635 Cr19.2%
Q2 FY26₹3,302 Cr₹591 Cr17.9%
Q1 FY26₹3,178 Cr₹548 Cr17.2%
Q4 FY25₹2,959 Cr₹498 Cr16.8%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 60.78% of Torrent Pharma Ltd.'s shares as of Sept 2026, against 68.31% in Dec 2025 (−7.53 percentage points). Delivery averaged 60.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Torrent Pharma Ltd.

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Products and Services

1. Generic Formulation Business-This segment engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations. It also engages in contract manufacturing business.

Business Segments

1. Generic Formulation Business-100%

Torrent Pharma Ltd. vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Infinium Pharmachem Limited₹436 Cr36.410.54%—+11.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Torrent Pharma Ltd.?

Torrent Pharma Ltd. is trading at ₹4,670.00, with a market capitalisation of ₹1,79,494 Cr.

Which sector does Torrent Pharma Ltd. belong to?

Torrent Pharma Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Torrent Pharma Ltd.?

Torrent Pharma Ltd. has a P/E of 73.6 and a return on equity of 16.98%.

What is the stock symbol of Torrent Pharma Ltd.?

Torrent Pharma Ltd. is listed on the BSE under the scrip code 500420.

How has Torrent Pharma Ltd.'s share price moved over the past year?

Torrent Pharma Ltd.'s share price is up 30.4% over one year and down 5.0% over three months. Its 52-week range is ₹3,672.30 to ₹5,250.00.

What were Torrent Pharma Ltd.'s latest quarterly results?

In Q2 FY27, Torrent Pharma Ltd. reported revenue of ₹4,979 Cr and net profit of ₹534 Cr, with basic EPS of ₹14.05 (consolidated, parsed from the company's exchange filing).

How have Torrent Pharma Ltd.'s revenue and profit changed over the past year?

Torrent Pharma Ltd. reported revenue of ₹4,979 Cr in Q2 FY27, up 50.8% from ₹3,302 Cr in Q2 FY26 and up 1.2% from ₹4,921 Cr in Q1 FY27.

What is the promoter holding in Torrent Pharma Ltd.?

Promoters held 60.78% of Torrent Pharma Ltd.'s shares as of Sept 2026, against 68.31% in Dec 2025 (−7.53 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.